Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals https://www.medrxiv.org/content/10.1101/2023.03.30.23287962
Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals https://www.medrxiv.org/content/10.1101/2023.03.30.23287962